Bioelectronica
- Company typePrivate
- Founded2016
- HeadquartersReno, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Bioelectronica firmographics
Firmographics- Name
- Bioelectronica
- Legal name
- Bioelectronica Holdings Inc.
- Website
- https://bioelectronica.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Bioelectronica industry classification
Industry- Product category
- Life Sciences Instrumentation
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening) (HLAAAIAE)
- akta.pro secondary industries
- Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB), Single-Cell & Spatial Omics Discovery Platforms (target ID/validation, functional profiling) (HLAAAIAF), Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE), Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
Keywords
Where Bioelectronica is headquartered
LocationHeadquarters
- HQ city
- Reno
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Bioelectronica business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Hardware Sales (Hypercell Device): Bioelectronica sells the Hypercell benchtop platform as a capital equipment device. The device is described as available at a fraction of the cost of less capable systems.
- Consumable Reagents: The Hypercell platform uses proprietary reagent kits and consumable chips. Customers purchase reagents for use with the device.
- AbFinderAI SaaS/On-Premises Licensing: AbFinderAI is available in Cloud (SaaS) and On-Premises deployments. The platform enables subscription-based access to AI-powered antibody sequence analysis and selection tools.
- Custom Assay Development Services: Bioelectronica offers custom assay development, cell-sorting and analysis services for interested customers. Customers can contact for service pricing based on their specific needs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Hypercell Device with Consumable Reagents |
| Subscription | Monthly | AbFinderAI Cloud (SaaS) |
| Subscription | Annual | AbFinderAI On-Premises |
| Other | Multi-year contract | Custom Assay Development Services |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
Bioelectronica product offering
Product offeringCore offering
Bioelectronica designs, manufactures, and sells the Hypercell high-throughput single-cell sorting platform, a benchtop device that uses proprietary PODS encapsulation and a lensless imaging microchip combined with computer vision to analyze and sort antibody-secreting cells without fluorescence or optical alignment. The company complements the instrument with proprietary reagent kits and consumable chips, and offers AbFinderAI as cloud (SaaS) or on-premises AI-powered bioinformatics software for downstream antibody candidate selection, plus SmartCulture X for automated microbial cultivation. Bioelectronica also provides custom assay development, cell-sorting, and analysis services on a project basis.
Product overview
Bioelectronica offers a platform-plus-modules architecture centered on three core products for life sciences research. Hypercell is a high-throughput single-cell sorting platform using computer vision and proprietary PODS technology for secretion-based analysis. AbFinderAI is the complementary AI-powered bioinformatics software that processes sequencing data and enables automated antibody candidate selection. SmartCulture X extends the platform to automated high-throughput microbial cultivation for culturomics applications. Together, these products leverage AI-driven data analysis and computer vision to transform biological observation workflows from subjective, labor-intensive processes into real-time, standardized data streams for antibody discovery and microbiome research.
Differentiator
Problem solved
Functional benefit
Brands
- Hypercell: High-throughput single-cell sorting platform based on computer vision for antibody discovery and cell analysis.
- AbFinderAI
- SmartCultureX
Products and services
- Hypercell Single-Cell Sorting Platform High-throughput, secretion-based single-cell sorting benchtop platform that uses computer vision and lensless imaging combined with proprietary PODS encapsulation to analyze and sort antibody-secreting cells without fluorescence or optical alignment. Compatible with multiple cell types (mouse, human, transgenic animal, camelid, rabbit) and assay types, and intended for biopharmaceutical companies and academic research labs working on antibody discovery, hybridoma screening, cell line development, vaccine development, and immunology research.
- AbFinderAI Bioinformatics Software AI-powered bioinformatics analysis platform for single-cell BCR sequencing data that uses next-generation sequencing and AI-driven models to perform sequence analysis, docking analysis, automated hit selection, developability prediction, and 3D antibody structure prediction. Available as Cloud (SaaS) and On-Premises deployments and designed for antibody discovery teams using 10x Genomics single-cell workflows.
- SmartCulture X Microbial Cultivation System Automated high-throughput aerobic and anaerobic microbial cultivation and isolation system that combines intelligent cultivation management with automated processing and an integrated AI algorithm engine and database. Reduces repetitive manual handling by over 80% and is intended for microbiome companies, probiotic developers, synthetic biology researchers, and industrial biotech labs working on culturomics, microbe discovery, and quality control.
- Custom Assay Development and Cell-Sorting Services Project-based services in which Bioelectronica develops custom assay reagents and runs cell-sorting and analysis workflows on the Hypercell platform for customers who need tailored single-cell or antibody discovery assays. Pricing is quote-based and contracts are structured around customer-specific project scope.
Quantifiable outcome
- Screening volume improved by hundreds of times compared to traditional methods
- +4 more outcomes
Companies that use Bioelectronica
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
Bioelectronica technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature5 records
Bioelectronica partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- GenScript Biotech CorporationcoreStrategic partnership announced May 20, 2025 to integrate Bioelectronica's globally leading single B cell high-throughput screening technology with GenScript's end-to-end antibody development service platform. GenScript has adopted Hypercell system and integrated it into existing services. The collaboration aims to help global biopharma companies break through R&D efficiency bottlenecks. Clone validation cycle can be shortened by more than 50%. Partnership includes plans for standardized workflow development, technology innovation expansion, and global market expansion over five years.
- PharmiGENEcoreExclusive distribution partnership announced May 1, 2025 with PharmiGENE, a leading life sciences company based in Taiwan. PharmiGENE serves as exclusive distributor in Taiwan, helping expand access to Bioelectronica's cutting-edge technologies across the region. PharmiGENE has strong track record delivering high-quality genomics and molecular biology solutions including 10x Genomics. Strategic alignment makes PharmiGENE ideal partner to support continued growth and customer success in Taiwan.
- Duoning Biotechnology GroupcoreStrategic partnership announced May 16, 2024 to enhance global commercialization of Hypercell high-throughput single-cell sorting system and related products. Duoning is a leading one-stop bioprocess provider in China with extensive global sales network. Both companies will provide economical and efficient solution for antibody discovery utilizing advanced target cells screening technology. Partnership supports researchers in precise manipulation and efficient screening of single cells, accelerating antibody development speed and simplifying biopharmaceutical R&D process.
- Cambridge Antibody LabsminorPartner listed on Bioelectronica's partners page. Located at 1 Grant Street, Ste 230, Framingham, MA 01702, USA.
- America DiagnosticsminorPartner listed on Bioelectronica's partners page. Located at 9235 Activity Road, Suite 101, San Diego, CA 92126, USA.
- Ab StudiominorPartner listed on Bioelectronica's partners page. Located at 3541 Investment Blvd. Suite 3, Hayward, CA 94545, USA.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Bioelectronica competitors and assessment
Company assessmentDirect peers
- 10x Genomics: Leading single-cell analysis platform offering Chromium controllers and配套 reagents. Directly competes with Bioelectronica in single-cell antibody discovery workflows and is referenced by Bioelectronica itself as a compatible workflow partner.
- Berkeley Lights (now PhenomeX): Commercialized the Beacon single-cell functional screening platform, the closest direct competitor to Hypercell's secretion-based sorting. Both target antibody discovery and cell line development at biopharma with benchtop, computer-vision-driven instruments.
- AbCellera Biologics: AI-powered antibody discovery company that uses single-cell microfluidic screening and machine learning to identify therapeutic antibodies. Directly comparable in target customers, use cases (antibody discovery), and end-to-end discovery positioning.
- Standard BioTools (formerly Fluidigm): Provides mass cytometry and microfluidic single-cell platforms (e.g., CyTOF, Hyperion, Biomark) used in immunology and antibody research. Comparable in targeting single-cell biology customers with instrument + consumable business models.
- NanoCellect Biomedical: Makes the WOLF cell sorter, a microfluidic, gentle benchtop cell-sorting instrument targeting antibody discovery and genomics workflows. Closely aligned with Bioelectronica's benchtop, low-pressure, gentle-sorting positioning.
- Sphere Fluidics: Develops picodroplet-based single-cell analysis and sorting platforms (Cyto-Mine) for antibody discovery and cell line development. Directly comparable in microfluidic single-cell screening technology and biopharma customer base.
Broad incumbents
- Becton, Dickinson and Company (BD Biosciences): Sells the industry-standard BD FACSDiscover and cell-sorting instruments used in antibody discovery and immunology research. A broad incumbent whose flow cytometry and cell-sorting products overlap with Bioelectronica's Hypercell at larger biopharma accounts.
- Cytek Biosciences: Provides full-spectrum flow cytometry instruments and reagents broadly used in immunology and cell biology research. Competes with Bioelectronica in cell-sorting and analytical workflows but focuses on fluorescence-based cytometry.
- Bio-Techne: Diversified life science tools and reagents provider including single-cell gene analysis (RNAscope) and proteomics. A broad incumbent whose reagents, antibodies, and analytical tools overlap with Bioelectronica's research-institution customer base.
Others
- GenScript Biotech: Strategic OEM partner and global CRO offering end-to-end antibody discovery services. Embedded Bioelectronica's Hypercell into its service platform, making it both a partner and an adjacent antibody-discovery service peer.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Bioelectronica social profiles
Digital presenceBioelectronica financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bioelectronica leadership team
Management profileNumber of profiles
Profiles2 records
Bioelectronica funding detail
Funding detailFunding overview
Funding rounds2 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bioelectronica M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bioelectronica
What does Bioelectronica do?
Bioelectronica designs, manufactures, and sells the Hypercell high-throughput single-cell sorting platform, a benchtop device that uses proprietary PODS encapsulation and a lensless imaging microchip combined with computer vision to analyze and sort antibody-secreting cells without fluorescence or optical alignment. The company complements the instrument with proprietary reagent kits and consumable chips, and offers AbFinderAI as cloud (SaaS) or on-premises AI-powered bioinformatics software for downstream antibody candidate selection, plus SmartCulture X for automated microbial cultivation. Bioelectronica also provides custom assay development, cell-sorting, and analysis services on a project basis.
Is Bioelectronica a public or private company?
Bioelectronica is a private company. It is classified as venture growth investor backed and is currently operating.
When was Bioelectronica founded?
Bioelectronica was founded in 2016. It employs 11 to 50 people.
Where is Bioelectronica based?
Bioelectronica is headquartered in Reno, United States, in the North America region.
How does Bioelectronica make money?
Four revenue lines are on record. Hardware Sales (Hypercell Device) is the primary driver. The others are consumable Reagents, abFinderAI SaaS/On-Premises Licensing and custom Assay Development Services.
Who are Bioelectronica's main competitors?
Direct peers on record are 10x Genomics, Berkeley Lights (now PhenomeX), AbCellera Biologics, Standard BioTools (formerly Fluidigm), NanoCellect Biomedical and Sphere Fluidics. Broad incumbents are Becton, Dickinson and Company (BD Biosciences), Cytek Biosciences and Bio-Techne. GenScript Biotech is listed as an others.
Does Bioelectronica have an API?
No public API is recorded for Bioelectronica.
What industry is Bioelectronica in?
Bioelectronica's product category is Life Sciences Instrumentation. Its primary akta.pro industry code is HLAAAIAE, AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening), with a secondary code of HLAAAIAB, Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering). Its NAICS code is 541714 and its SIC code is 3826.